DOI QR코드

DOI QR Code

Intravascular Ultrasound-Guided Percutaneous Coronary Intervention Improves the Clinical Outcome in Patients Undergoing Multiple Overlapping Drug-Eluting Stents Implantation

  • Ahn, Sung Gyun (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Yoon, Junghan (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Sung, Joong Kyung (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Lee, Ji-Hyun (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Lee, Jun-Won (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Youn, Young-Jin (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Ahn, Min-Soo (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Kim, Jang-Young (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Yoo, Byung-Su (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Lee, Seung-Hwan (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
  • Choe, Kyung-Hoon (Division of Cardiology, Wonju College of Medicine, Yonsei University)
  • Published : 2013.04.30

Abstract

Background and Objectives: Stented segment length is a predictive factor for restenosis and stent thrombosis still in the drug-eluting stent (DES) era, and the benefit of routine intravascular ultrasound (IVUS) is still unclear. The aim of the present study was to investigate whether IVUS-guided percutaneous coronary intervention (PCI) improved the vascular outcomes as compared with conventional PCI in the treatment of diffuse coronary artery disease. Subjects and Methods: From our registry database from January 2006 to May 2009, we identified 85 consecutive patients with de novo coronary lesions treated with at least 64 mm of multiple, overlapping DES. The 2-year rate of major adverse cardiovascular events (MACE), defined as the composite of cardiovascular death, non-fatal myocardial infarction, target lesion revascularization (TLR), or stent thrombosis, was compared according to the use of IVUS. Results: The 2-year MACE rate was lower in the IVUS-guided group than that of the angiography-guided group (8% vs. 33.3%, p=0.005). The incidence of TLR was lower in patients with IVUS use than in those without IVUS use (0% vs. 27.8%, p<0.001). On Cox proportional hazard analysis, no IVUS use {hazard ratio (HR) 5.917, 95% confidence interval (CI) 1.037-33.770, p=0.045} and age (HR 1.097, 95% CI 1.006-1.138, p=0.032) were unfavorable predictors for the 2-year MACE. Conclusion: The use of IVUS may improve the effectiveness and safety of multiple overlapping drug-eluting stenting for long, diffuse coronary lesions.

Keywords

References

  1. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network metaanalysis. Lancet 2007;370:937-48. https://doi.org/10.1016/S0140-6736(07)61444-5
  2. Hannan EL, Racz M, Holmes DR, et al. Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drugeluting stents. Circulation 2008;117:2071-8. https://doi.org/10.1161/CIRCULATIONAHA.107.725531
  3. Aoki J, Ong AT, Rodriguez Granillo GA, et al. "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 2005;150:994-9. https://doi.org/10.1016/j.ahj.2005.01.050
  4. Lee CW, Park KH, Kim YH, et al. Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions. Am J Cardiol 2006;98:918-22. https://doi.org/10.1016/j.amjcard.2006.05.011
  5. Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010;56:1897-907. https://doi.org/10.1016/j.jacc.2010.07.028
  6. Hong SJ, Kim MH, Ahn TH, et al. Comparison of the predictors of coronary restenosis after drug-eluting stent implantation in diabetic and nondiabetic patients. Korean Circ J 2007;37:530-7. https://doi.org/10.4070/kcj.2007.37.11.530
  7. Tin-Hay EL, Poh KK, Lim YT, et al. Clinical predictors of stent thrombosis in the "real world" drug-eluting stent era. Int J Cardiol 2010;145:422-5. https://doi.org/10.1016/j.ijcard.2009.05.038
  8. Brugaletta S, Costa JR Jr, Garcia-Garcia HM. Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities. Int J Cardiovasc Imaging 2011;27:239-48. https://doi.org/10.1007/s10554-010-9788-8
  9. Roy P, Steinberg DH, Sushinsky SJ, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 2008;29:1851-7. https://doi.org/10.1093/eurheartj/ehn249
  10. Claessen BE, Mehran R, Mintz GS, et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv 2011;4:974-81. https://doi.org/10.1016/j.jcin.2011.07.005
  11. Ahmed K, Jeong MH, Chakraborty R, et al. Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011;108:8-14. https://doi.org/10.1016/j.amjcard.2011.02.339
  12. Youn YJ, Yoon J, Lee JW, et al. Intravascular ultrasound-guided primary percutaneous coronary intervention with drug-eluting stent implantation in patients with ST-segment elevation myocardial infarction. Clin Cardiol 2011;34:706-13. https://doi.org/10.1002/clc.20966
  13. Maluenda G, Lemesle G, Ben-Dor I, et al. Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2010;75:86-92.
  14. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114-30. https://doi.org/10.1016/S0735-1097(01)01702-8
  15. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-54. https://doi.org/10.1016/j.jacc.2012.09.001
  16. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Winjs W, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55. https://doi.org/10.1093/eurheartj/ehq277
  17. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574-651. https://doi.org/10.1161/CIR.0b013e31823ba622
  18. Hur SH, Kang SJ, Kim YH, et al. Impact of intravascular ultrasoundguided percutaneous coronary intervention on long-term clinical outcomes in a real world population. Catheter Cardiovasc Interv 2011. [Epub ahead of print]
  19. Park SJ, Kim YH, Park DW, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2009;2:167-77. https://doi.org/10.1161/CIRCINTERVENTIONS.108.799494
  20. Kim SH, Kim YH, Kang SJ, et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol 2010;106:612-8. https://doi.org/10.1016/j.amjcard.2010.04.016
  21. Kim JS, Hong MK, Ko YG, et al. Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: data from a Korean multicenter bifurcation registry. Am Heart J 2011;161:180-7. https://doi.org/10.1016/j.ahj.2010.10.002
  22. Hong MK, Mintz GS, Lee CW, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 2006;27:1305-10. https://doi.org/10.1093/eurheartj/ehi882
  23. Okabe T, Mintz GS, Buch AN, et al. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 2007;100:615-20. https://doi.org/10.1016/j.amjcard.2007.03.072
  24. Cook S, Ladich E, Nakazawa G, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009;120:391-9. https://doi.org/10.1161/CIRCULATIONAHA.109.854398

Cited by

  1. How clinically effective is intravascular ultrasound in interventional cardiology? Present and future perspectives vol.10, pp.6, 2013, https://doi.org/10.1586/17434440.2013.841353
  2. Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis vol.15, pp.None, 2013, https://doi.org/10.1186/s12872-015-0144-8
  3. Intravascular ultrasound-guided drug-eluting stent implantation: An updated meta-analysis of randomized control trials and observational studies vol.216, pp.None, 2013, https://doi.org/10.1016/j.ijcard.2016.04.154
  4. Intravascular ultrasound guidance improves patient survival (mortality) after drug-eluting stent implantation: review and updated bibliography vol.35, pp.1, 2013, https://doi.org/10.1007/s12928-019-00616-7
  5. Ultrasound-Guided Percutaneous Balloon Aortic Valvuloplasty for Aortic Stenosis vol.2020, pp.None, 2013, https://doi.org/10.1155/2020/8086796
  6. Short- and Long-Term Prognosis of Intravascular Ultrasound-Versus Angiography-Guided Percutaneous Coronary Intervention: A Meta-Analysis Involving 24,783 Patients vol.2021, pp.None, 2013, https://doi.org/10.1155/2021/6082581